Public trial registry of the CCC-Munich

Trial A536-03 MDS (Acceleron)

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
A536-03 MDS (Acceleron)
World
Full title
:

A Phase 2, Open-Label, Ascending Dose Study of ACE-536 for the Treatment of Anemia in Patients with Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
Z-Nummer: 303

World
NCT number
:
World
Responsible organization
:
3. Med 3. Med Ismaninger Str. 22 81675 München Germany Tum
Indications
Classification Code Description
- D46 Myelodysplastische Syndrome
Trial design
World
Phase
:
II
Status
World
Status
:
Recruitment active
Votes
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Chemo,Sonstige

Participants
Function Prename Surname Organization
World Responsible contact Katharina Götze Keine Organisationseinheit angegeben Magnifier